Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Menu
Eileen Scully, MD, PhD
Eileen Scully, MD, PhD
Assistant Professor of Medicine
The Johns Hopkins University
Baltimore, MD
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Practice Question of the Week
July 7, 2025: Recent Clinical Trial Evidence for Bacteriophage Therapeutics
Which of the following was demonstrated in recently completed clinical trials of bacteriophage therapeutics?
A. No evidence of antimicrobial activity in vivo
B. Substantial toxicity when given by rapid intravenous administration
C. Improvement in clinical and microbiologic outcomes in patients with complex S aureus bacteremia
D No antimicrobial activity against E coli in urine unless an effective antibiotic is coadministered
View the On-Demand Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
